Evidence map›Paper›PMID 34258294›Full record

ArticleJournal of diabetes research2021

Residual

Kun Lin, Xiaoping Yang, Yixi Wu, Shuru Chen, Qiong Zeng

Erratum issuedAbstract read
In one paragraph

Article in Journal of diabetes research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Corrigendum to "ResidualJournal of diabetes research · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Kun LinDepartment of Endocrinology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.ORCID https://orcid.org/0000-0003-1714-7183
Xiaoping YangDepartment of Endocrinology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.ORCID https://orcid.org/0000-0001-6986-0939
Yixi WuDepartment of Endocrinology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.ORCID https://orcid.org/0000-0002-8001-2727
Shuru ChenShenzhen Huada Gene Technology Service Co., Ltd, Shenzhen, China.ORCID https://orcid.org/0000-0001-9171-6335
Qiong ZengDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.ORCID https://orcid.org/0000-0002-9449-566X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the natural history and related factors of the pancreatic

methodStimulated C-peptide levels from follow-up data of 201 individuals in 3C study Shantou subgroup starting in 2012 were used. Residual

results36.8% of patients had residual

conclusionAge at diagnosis was the strongest predictor for residual C-peptide. There was a more rapid decline of stimulated C-peptide in duration ≤5 years and younger patients. Therefore, intervention therapies of

Indexed as

Insulin SecretionAdolescentAdultAge of OnsetChildC-PeptideDiabetes Mellitus, Type 1Disease ProgressionFemaleFollow-Up StudiesGlycated HemoglobinHumansInsulin-Secreting CellsMaleProportional Hazards ModelsTime FactorsC-PeptideGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID34258294
PMCPMC8261175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.